Scarica l'app Stockscreener
37.10
0.24%
0.09
Precedente Chiudi:
$37.01
Aprire:
$37.02
Volume 24 ore:
395.97K
Relative Volume:
0.55
Capitalizzazione di mercato:
$1.61B
Reddito:
$384.10M
Utile/perdita netta:
$-9.07M
Rapporto P/E:
-265.00
EPS:
-0.14
Flusso di cassa netto:
$11.10M
1 W Prestazione:
+3.89%
1M Prestazione:
+13.18%
6M Prestazione:
+64.89%
1 anno Prestazione:
+51.49%
Intervallo 1D:
$36.40
$37.34
Intervallo di 1 settimana:
$35.45
$37.34
Portata 52W:
$17.82
$37.34
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile
Nome
Kiniksa Pharmaceuticals International Plc
Settore
Telefono
(781) 431-9100
Indirizzo
23 OLD BOND STREET, FLOOR 3, LONDON
Confronta KNSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KNSA
Kiniksa Pharmaceuticals International Plc
|
37.10 | 2.68B | 384.10M | -9.07M | 11.10M | -0.14 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2024-05-03 | Iniziato | Wells Fargo | Overweight |
| 2020-06-29 | Reiterato | BofA Securities | Buy |
| 2020-04-01 | Iniziato | BofA/Merrill | Buy |
| 2019-03-11 | Iniziato | Barclays | Overweight |
| 2018-12-12 | Reiterato | Wedbush | Outperform |
| 2018-06-19 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Kiniksa Pharmaceuticals International Plc Borsa (KNSA) Ultime notizie
Acadian Asset Management LLC Grows Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
AQR Capital Management LLC Has $10.92 Million Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $477,451.74 in Stock - MarketBeat
Eben Tessari Sells 85,271 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
American Century Companies Inc. Trims Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighWhat's Next? - MarketBeat
Cubist Systematic Strategies LLC Takes $4.66 Million Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Ross Moat Sells 3,523 Shares - MarketBeat
Granahan Investment Management LLC Has $8.04 Million Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Michael R. Megna Sells 11,000 Shares - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 12-Month HighWhat's Next? - MarketBeat
PDT Partners LLC Cuts Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 15,091 Shares of Stock - MarketBeat
Kiniksa Pharma: Chief corp officer Moat Ross sells $124k in shares - Investing.com Canada
Kiniksa Pharma COO Tessari sells shares worth $3.5m - Investing.com
Ieq Capital LLC Purchases New Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
169,864 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Vestal Point Capital LP - MarketBeat
Corebridge Financial Inc. Buys 549 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Invesco Ltd. Raises Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Birchview Capital LP Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Position Lowered by ADAR1 Capital Management LLC - MarketBeat
Trexquant Investment LP Has $5.25 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Braidwell LP Decreases Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Sold by American Century Companies Inc. - Defense World
Kiniksa Pharmaceuticals International, plc $KNSA Holdings Boosted by Wellington Management Group LLP - MarketBeat
Hsbc Holdings PLC Cuts Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Charles Schwab Investment Management Inc. Has $3.65 Million Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kodai Capital Management LP Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharma COO Tessari sells $535k in shares By Investing.com - Investing.com Australia
Kiniksa Pharma COO Tessari sells $535k in shares - Investing.com
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Kiniksa Pharmaceuticals shares rise 3.03% intraday after presenting at Citi's Biopharma and Back-to-school Conference. - AInvest
Walleye Capital LLC Invests $1.92 Million in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here - sharewise.com
Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why - Yahoo Finance
Kiniksa Pharmaceuticals Highlights Cardiovascular Focus and Growth - TipRanks
Kiniksa Q4 rev. down 40% YoY, FY22 rev. down 49% YoY. - AInvest
Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.67%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):